IPSEN – Buy-back programme – Art 5 of MAR – Week 40 – 2025
| Aggregated presentation by day and by market
Statement of transactions in own shares from September 29th to October 03rd 2025 |
||||||
| Name of the issue | Identity code of the issuer (Legal Entity Identifier) |
Day of the transaction | Identity code of the financial instrument | Total daily volume (in number of shares) | Daily weighted average purchase price of the shares | Market (MIC Code) |
| IPSEN | 549300M6SGDPB4Z94P11 | 01/10/2025 | FR0010259150 | 3000 | 117,92043 | XPAR |
| IPSEN | 549300M6SGDPB4Z94P11 | 02/10/2025 | FR0010259150 | 200 | 116,15 | AQEU |
| IPSEN | 549300M6SGDPB4Z94P11 | 02/10/2025 | FR0010259150 | 1267 | 115,80513 | CCXE |
| IPSEN | 549300M6SGDPB4Z94P11 | 02/10/2025 | FR0010259150 | 200 | 116,00 | TQEX |
| IPSEN | 549300M6SGDPB4Z94P11 | 02/10/2025 | FR0010259150 | 4334 | 116,84149 | XPAR |
| IPSEN | 549300M6SGDPB4Z94P11 | 03/10/2025 | FR0010259150 | 800 | 115,40 | CCXE |
| IPSEN | 549300M6SGDPB4Z94P11 | 03/10/2025 | FR0010259150 | 3399 | 115,93569 | XPAR |
| IPSEN | 549300M6SGDPB4Z94P11 | 29/09/2025 | FR0010259150 | 300 | 111,86633 | AQEU |
| IPSEN | 549300M6SGDPB4Z94P11 | 29/09/2025 | FR0010259150 | 1200 | 112,36667 | CCXE |
| IPSEN | 549300M6SGDPB4Z94P11 | 29/09/2025 | FR0010259150 | 300 | 111,80 | TQEX |
| IPSEN | 549300M6SGDPB4Z94P11 | 29/09/2025 | FR0010259150 | 2800 | 112,32536 | XPAR |
| IPSEN | 549300M6SGDPB4Z94P11 | 30/09/2025 | FR0010259150 | 273 | 113,25641 | AQEU |
| IPSEN | 549300M6SGDPB4Z94P11 | 30/09/2025 | FR0010259150 | 1343 | 113,35957 | CCXE |
| IPSEN | 549300M6SGDPB4Z94P11 | 30/09/2025 | FR0010259150 | 245 | 113,58163 | TQEX |
| IPSEN | 549300M6SGDPB4Z94P11 | 30/09/2025 | FR0010259150 | 2739 | 113,57327 | XPAR |
| 22400 | 115,09863 | |||||
Attachment
Ipsen to acquire ImCheck Therapeutics, expanding its leadership in oncology, strengthening its pipeline
IPSEN – Buy-back programme – Art 5 of MAR – Week 42 – 2025
IPSEN – Buy-back programme – Art 5 of MAR – Week 41 – 2025
Ipsen – September 2025 – Monthly information relative to the total number of voting rights and shares composing the share capital
IPSEN – Buy-back programme – Art 5 of MAR – Week 39 – 2025
IPSEN – Buy-back programme – Art 5 of MAR – Week 38 – 2025
IPSEN – Buy-back programme – Art 5 of MAR – Week 37 – 2025
Ipsen – August 2025 – Monthly information relative to the total number of voting rights and shares composing the share capital
IPSEN – Buy-back programme – Art 5 of MAR – Week 36 – 2025
IPSEN – Buy-back programme – Art 5 of MAR – Week 35 – 2025